Overall, very encouraging data for both semaglutide and tirzepatide with respect to neuropsychiatric safety This is important as patents with obesity often have psychiatric comorbidities The profiles for semaglutide and tirzepatide were generally similar #semaglutide #tirzepatide #neuropsychiatricoutcomes #anxiety #depression #obesity #weightloss To view or add a comment, sign in "Major depressive disorder (MDD) remains one of the leading causes of disability worldwide, with many patients failing to achieve adequate symptom control despite multiple available antidepressants
In all the studies, the combined therapy was superior to other diabetes treatment options or each medication separately in reducing HbA1c and weight
Where a BMI of 30 typically marks the obesity threshold, lupus patients may see complications starting at a BMI of 26.8 or higher
Supports Healthy Neurological Function : The compound supports nerve growth factor activity and helps maintain myelin sheath integrity, contributing to overall neurotransmitter effectiveness and neural communication
S2E40 Hi folks, welcome to another episode of Who Said What
The acetylated form of glutathione is more resistant to degradation, ensuring that more of the active ingredient reaches your cells
